Another under-$10 stock that's trending within range of triggering a near-term breakout trade is Supernus Pharmaceuticals ( SUPN), which is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system, or CNS, diseases. This stock has been destroyed by the sellers during the last six months, with shares off by 39%. If you take a look at the chart for Supernus Pharmaceuticals, you'll notice that this stock has been trending range-bound for the last two months, after gapping down from $11 a share in early December. That range-bound action has shares of SUPN moving between $6.75 on the downside and just below $8 a share on the upside. This stock has also started to trend higher off that low of $6.75 a share and it's quickly moving within range of breaking out above the upper end of its recent sideways trading pattern. >>4 Breakout Buys for January -- and One Sell Market players should now look for long-biased trades in SUPN if it manages to break out above some near-term overhead resistance level $7.79 to $8 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action 242,700 shares. If that breakout hits soon, then SUPN will set up to re-fill some of that previous gap down zone that started around $11 a share. Traders can look to buy SUPN off any weakness to anticipate that breakout and then simply use a stop that sits close to some near-term support levels at $7 to $6.93 a share. One can also buy off strength once SUPN takes out those breakout levels with volume and then simply use a stop that sits just below $7.50 a share. I would add to either position once SUPN takes out its 50-day moving average of $8.55 a share with heavy volume.